SUNPHARMA's weekly performance was disappointing, with a return of -3.73% and a Sharpe Ratio of -0.52, indicating poor risk-adjusted returns. The stock's volatility was exceptionally high at 37.85%, making it a risky investment this week. Compared to its peers, SUNPHARMA underperformed, with a worse return and higher volatility than DRREDDY, DIVISLAB, and HINDUNILVR. 

[Volatility: 37.85%]